Laurence Morand‐Joubert

Author

Also Known As

D Costagliola, F. Ferchal, Geneviève Chêne, JL Meynard, Julie Fillon, L Morand-Joubert, L Morand‐Joubert, L. Morand-Joubert, L. Morand‐Joubert, LAURENCE MORAND-JOUBERT

211

Publications

4.4K

Citations

H-Index

Concepts

All Affiliations

Sorbonne Université Inserm Assistance Publique – Hôpitaux de Paris Hôpital Saint-Antoine Université Paris Cité

About

Laurence Morand‐Joubert is an author at Sorbonne Université specializing in medicine, hiv, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	777
2	Public Health	5	5	158
3	Biostatistics	2	2	96
4	Natural Sciences	1	1	39
5	Allergy	1	1	11

Laurence Morand‐Joubert

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial Jean‐Luc Meynard, Muriel Vray, Laurence Morand‐Joubert, AIDS	2002	244
Carriage of GB Virus C/Hepatitis G Virus RNA Is Associated with a Slower Immunologic, Virologic, and Clinical Progression of Human Immunodeficiency Virus Disease in Coinfected Persons Jean‐Jacques Lefrère, Françoise Roudot‐Thoraval, Laurence Morand‐Joubert, The Journal of Infectious Diseases ImmunologyPathologySlower ImmunologicClinical ProgressionRna Status	1999	147
Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies Florent Malard, Béatrice Gaugler, Joël Gozlan, Blood Cancer Journal	2021	139
Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study Lawrence Serfaty, Olivier Chazouillères, Armelle Poujol‐Robert, Hepatology	1997	124
Detection of Minority Populations of HIV-1 Expressing the K103N Resistance Mutation in Patients Failing Nevirapine Denise Lecossier, Nancy S. Shulman, Laurence Morand‐Joubert, JAIDS Journal of Acquired Immune Deficiency Syndromes	2004	104
Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. Daniel Vittecoq, Sylvie Chevret, Laurence Morand‐Joubert, Proceedings of the National Academy of Sciences	1995	91
Even Individuals Considered as Long-Term Nonprogressors Show Biological Signs of Progression After 10 Years of Human Immunodeficiency Virus Infection Jean‐Jacques Lefrère, Laurence Morand‐Joubert, Martine Mariotti, Blood	1997	82
Full or Partial Seroreversion in Patients Infected by Hepatitis C Virus J.‐J. Lefrère, Sonia Guiramand, François Lefrère, The Journal of Infectious Diseases Hepatitis C VirusImmunologyHepatitis BPathologyViral Persistence	1997	81
First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022 Anna Maisa, Guillaume Spaccaferri, Justine Schaeffer, Infectious Diseases Now	2022	75
Clinical phenotypes and outcomes associated with SARS-CoV-2 variant Omicron in critically ill French patients with COVID-19 Nicolas de Prost, Étienne Audureau, Nicholas Heming, Nature Communications	2022	75

Page 1